These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 6337809)

  • 21. [Chloroquine and pyrimethamine/sulfadoxine resistant malaria tropica in a child with diabetes mellitus].
    Kroll MH; Bienzle U; Burger W; Weber B
    Monatsschr Kinderheilkd; 1984 May; 132(5):301-2. PubMed ID: 6379425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
    Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
    P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kenyan chloroquin, fansidar and quninine resistant P. Falciparum.
    Turner GD
    Cent Afr J Med; 1984 Jul; 30(7):136-7. PubMed ID: 6386173
    [No Abstract]   [Full Text] [Related]  

  • 24. Practical therapeutics malaria chemoprophylaxis.
    Juma FD
    East Afr Med J; 1984 Mar; 61(3):254-9. PubMed ID: 6383777
    [No Abstract]   [Full Text] [Related]  

  • 25. [Monitoring the chemoresistance of Plasmodium falciparum malaria in Yopougon (Abidjan): in vivo study of chloroquine sensitivity and evaluation of pyrimethamine resistance following the analysis of point mutation in the dihydrofolate reductase gene].
    Djaman AJ; Basco LK; Mazabraud A
    Sante; 2002; 12(4):363-7. PubMed ID: 12626289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imported cases of chloroquine-resistant falciparum malaria in Iran.
    Edrissian GH; Shahabi S; Pishva E; Hajseyed-Javadi J; Khaleghian B; Ghorbani M; Emadi AM; Afshar A; Saghari H
    Bull Soc Pathol Exot Filiales; 1986; 79(2):217-21. PubMed ID: 3524879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Malaria in Switzerland].
    Fernex M
    Schweiz Med Wochenschr; 1988 Dec; 118(49):1838-43. PubMed ID: 3064291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined chloroquine/Fansidar-resistant falciparum malaria appears in East Africa.
    Hess U; Timmermans PM; Jones M
    Am J Trop Med Hyg; 1983 Mar; 32(2):217-20. PubMed ID: 6340538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fansidar resistant Plasmodium falciparum infection in Surinam.
    Oostburg BF; Jozefzoon LM
    Trop Geogr Med; 1983 Sep; 35(3):243-7. PubMed ID: 6359597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
    Djaman J; Abouanou S; Basco L; Koné M
    Sante; 2004; 14(4):205-9. PubMed ID: 15745869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recrudescence, poor response or resistance to quinine of falciparum malaria in Thailand.
    Jaroonvesama N; Harinasuta T; Munangmanee L
    Southeast Asian J Trop Med Public Health; 1974 Dec; 5(4):504-9. PubMed ID: 4617311
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
    Fadeke Aderounmu A; Salako LA; Laoye AJ; Modupe Makinde J; Aina Adio R
    Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chemotherapy and chemoprophylaxis of malaria (author's transl)].
    Bruce-Chwatt LJ
    MMW Munch Med Wochenschr; 1976 Aug; 118(35):1097-1107. PubMed ID: 822313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
    Kolaczinski K; Durrani N; Rahim S; Rowland M
    Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in Nigerian children.
    Ekanem OJ; Weisfeld JS; Salako LA; Nahlen BL; Ezedinachi EN; Walker O; Breman JG; Laoye OJ; Hedberg K
    Bull World Health Organ; 1990; 68(1):45-52. PubMed ID: 2189585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chloroquine-resistant falciparum malaria from Malawi.
    Overbosch D; van den Wall Bake AW; Stuiver PC; van der Kaay HJ
    Trop Geogr Med; 1984 Mar; 36(1):71-2. PubMed ID: 6375051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of artemether (qinghaosu) in Plasmodium falciparum and P. vivax in Burma.
    Pe Than Myint ; Tin Shwe
    Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):19-22. PubMed ID: 3526578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of the emergence and spread of drug-resistant falciparum malaria in South-East Asia and Australasia.
    Verdrager J
    J Trop Med Hyg; 1986 Dec; 89(6):277-89. PubMed ID: 3543384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent chloroquine and Fansidar resistance of Plasmodium falciparum: an imported case from Gabon.
    Burchard GD; Winkler E
    Trop Geogr Med; 1988 Jan; 40(1):68-9. PubMed ID: 3289215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.